Search

info:eu-repo/semantics/nonPublished

BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. METHODS: Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients' subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. DISCUSSION: Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO d

Background Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. Methods Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients’ subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. Discussion Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO desi, SCOPUS: ar.j, info:eu-repo/semantics/published

info:eu-repo/semantics/nonPublished

Background: Migration is increasing worldwide, with accumulating evidence of disparities. Migrants and Ethnic Minorities (MEMs) are identified as one of the most vulnerable group in health provision. In the context of haematological cancer patients (HECPs), significant “racial” and ethnic disparities have been reported regarding incidence and survival rates. At the same time, HECPs are increasingly treated by Oral Anticancer Medications (OAMs), including for bridging to transplant, and oncohaematological teams have to deal with the survey of adherence. These two evolutions raise the question of MEMs' adherence and their integration in cancer adherence studies.Methods: We conducted a scoping review of scientific literature regarding adherence to treatment in MEMs patients, particularly to OAMs.Results: Data are still scarce regarding how cancer patients adhere to their medication plan, particularly for those with malignancies other than breast cancer.In HECPs, research has shown that poor adherence impacts the quality of response and the risk of relapse.Nowadays, adherence is understood as the complex interplay between predisposing factors, patients' knowledge and beliefs, and interactions between patients and clinicians.Recent findings underline differences and difficulties between physician and patient coming from different cultural and/or ethnic backgrounds. Little is known about miscommunication causes. This is not only a language issue but it is also intimately related to cultural differences in the way people think about health, disease and care.It would seem therefore reasonable to anticipate higher risk of poor adherence among MEMs in foreign context. Unfortunately, this population group seems to have been forgotten from adherence studies in oncology.If “race” or ethnicity have been frequently reported to be a predictor of poor adherence, these studies entail important limitations which prevent definite conclusions. Beyond the fact that most research studies, info:eu-repo/semantics/published

Background: Patients with malignant hemopathies are increasingly treated by Oral Anticancer Medications (OAMs), including for bridging to transplant. The control of outpatients' adherence to treatment is a real challenge for clinicians. It has been demonstrated that poor adherence impacts the quality of response to treatment and the risk of relapse. Recent studies underline the link between adherence and patients' knowledge and beliefs, and also patient-clinician interactions. Nonetheless, a key population group seems to be forgotten from research: Migrants and Ethnic Minorities (MEMs). MEMs have been identified as one of the most vulnerable groups in health care provision and recent findings underline considerable disparities and difficulties in communication between doctors and patients from different cultural and/or ethnic backgrounds. It seems therefore reasonable to anticipate a higher risk of poor adherence among MEMs.Methods: Between 2012 and 2017, we conducted a 2 consecutive questionnaire-based survey which investigated 24 Healthcare Professionals' (HCPs) comfort and ability to take care for MEMs and 58 MEMs patients' satisfaction regarding their experience of transplantation. Subsequently, we conducted a scoping review of the scientific literature regarding MEMs' adherence to OAMs.Results: First survey revealed that 76% of HCPs had difficulties to care for foreign patients and that the sole presence of Intercultural Mediation (IM) services was not enough to ensure a high quality of care for this population. Also, patients' satisfaction survey allows to highlight the strong presence of MEMs in our regular patients. Half of the participants were born abroad and 40% did not have French or Dutch as their mother language. Among those speaking little or not at all French, only a few were informed about the existence of IM services. MEMs´ Satisfaction score was not lower. The results of the scoping review confirm unequal situations for MEMs in cancer care and hig, info:eu-repo/semantics/published

info:eu-repo/semantics/nonPublished

info:eu-repo/semantics/published

info:eu-repo/semantics/nonPublished

info:eu-repo/semantics/nonPublished